MARA HOLDINGS INC (M44.DE) Stock Fundamental Analysis

FRA:M44 • US5657881067

6.144 EUR
-0.31 (-4.77%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, M44 scores 3 out of 10 in our fundamental rating. M44 was compared to 122 industry peers in the Software industry. Both the profitability and financial health of M44 have multiple concerns. M44 shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year M44 was profitable.
  • In the past year M44 has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: M44 reported negative net income in multiple years.
  • In the past 5 years M44 always reported negative operating cash flow.
M44.DE Yearly Net Income VS EBIT VS OCF VS FCFM44.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

  • M44 has a better Return On Assets (10.12%) than 74.59% of its industry peers.
  • M44's Return On Equity of 17.96% is fine compared to the rest of the industry. M44 outperforms 70.49% of its industry peers.
Industry RankSector Rank
ROA 10.12%
ROE 17.96%
ROIC N/A
ROA(3y)-12.16%
ROA(5y)-8.47%
ROE(3y)-49.6%
ROE(5y)-31.52%
ROIC(3y)N/A
ROIC(5y)N/A
M44.DE Yearly ROA, ROE, ROICM44.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

  • M44 has a better Profit Margin (100.82%) than 98.36% of its industry peers.
  • The Operating Margin and Gross Margin are not available for M44 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 100.82%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
M44.DE Yearly Profit, Operating, Gross MarginsM44.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • M44 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for M44 has been increased compared to 1 year ago.
  • The number of shares outstanding for M44 has been increased compared to 5 years ago.
  • Compared to 1 year ago, M44 has a worse debt to assets ratio.
M44.DE Yearly Shares OutstandingM44.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
M44.DE Yearly Total Debt VS Total AssetsM44.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • M44 has an Altman-Z score of 0.43. This is a bad value and indicates that M44 is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.43, M44 is not doing good in the industry: 77.87% of the companies in the same industry are doing better.
  • M44 has a Debt/Equity ratio of 0.63. This is a neutral value indicating M44 is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.63, M44 is doing worse than 68.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z 0.43
ROIC/WACCN/A
WACC8.78%
M44.DE Yearly LT Debt VS Equity VS FCFM44.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • M44 has a Current Ratio of 2.09. This indicates that M44 is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.09, M44 is doing good in the industry, outperforming 77.05% of the companies in the same industry.
  • M44 has a Quick Ratio of 2.09. This indicates that M44 is financially healthy and has no problem in meeting its short term obligations.
  • M44 has a better Quick ratio (2.09) than 77.05% of its industry peers.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.09
M44.DE Yearly Current Assets VS Current LiabilitesM44.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • M44 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 128.21%, which is quite impressive.
  • M44 shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.32%.
  • Measured over the past years, M44 shows a very strong growth in Revenue. The Revenue has been growing by 252.85% on average per year.
EPS 1Y (TTM)128.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%173.81%
Revenue 1Y (TTM)20.32%
Revenue growth 3Y60.35%
Revenue growth 5Y252.85%
Sales Q2Q%91.73%

3.2 Future

  • M44 is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -34.97% yearly.
  • Based on estimates for the next years, M44 will show a very strong growth in Revenue. The Revenue will grow by 27.19% on average per year.
EPS Next Y-67.57%
EPS Next 2Y-77.4%
EPS Next 3Y-34.97%
EPS Next 5YN/A
Revenue Next Year49.78%
Revenue Next 2Y30.65%
Revenue Next 3Y23.77%
Revenue Next 5Y27.19%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
M44.DE Yearly Revenue VS EstimatesM44.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
M44.DE Yearly EPS VS EstimatesM44.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 4.10, the valuation of M44 can be described as very cheap.
  • Based on the Price/Earnings ratio, M44 is valued cheaper than 95.90% of the companies in the same industry.
  • M44 is valuated cheaply when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • M44 is valuated quite expensively with a Price/Forward Earnings ratio of 157.37.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of M44 indicates a slightly more expensive valuation: M44 is more expensive than 65.57% of the companies listed in the same industry.
  • M44 is valuated expensively when we compare the Price/Forward Earnings ratio to 27.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.1
Fwd PE 157.37
M44.DE Price Earnings VS Forward Price EarningsM44.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
M44.DE Per share dataM44.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A cheap valuation may be justified as M44's earnings are expected to decrease with -34.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-77.4%
EPS Next 3Y-34.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for M44!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MARA HOLDINGS INC

FRA:M44 (2/12/2026, 7:00:00 PM)

6.144

-0.31 (-4.77%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-04
Earnings (Next)03-04
Inst Owners77.68%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap2.32B
Revenue(TTM)919.17M
Net Income(TTM)926.69M
Analysts76.19
Price Target18.38 (199.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)84.39%
Min EPS beat(2)-31.5%
Max EPS beat(2)200.28%
EPS beat(4)2
Avg EPS beat(4)-998.97%
Min EPS beat(4)-4177.95%
Max EPS beat(4)200.28%
EPS beat(8)4
Avg EPS beat(8)-253.61%
EPS beat(12)6
Avg EPS beat(12)-155.42%
EPS beat(16)6
Avg EPS beat(16)-179.65%
Revenue beat(2)1
Avg Revenue beat(2)2.04%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)5.37%
Revenue beat(4)2
Avg Revenue beat(4)2.62%
Min Revenue beat(4)-6.36%
Max Revenue beat(4)12.77%
Revenue beat(8)3
Avg Revenue beat(8)-2.24%
Revenue beat(12)4
Avg Revenue beat(12)-4.59%
Revenue beat(16)5
Avg Revenue beat(16)-7.87%
PT rev (1m)-6.1%
PT rev (3m)-16.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-410.99%
EPS NY rev (1m)-59.33%
EPS NY rev (3m)-82.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.4%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-2.38%
Valuation
Industry RankSector Rank
PE 4.1
Fwd PE 157.37
P/S 3.01
P/FCF N/A
P/OCF N/A
P/B 0.54
P/tB 0.54
EV/EBITDA N/A
EPS(TTM)1.5
EY24.41%
EPS(NY)0.04
Fwd EY0.64%
FCF(TTM)-2.94
FCFYN/A
OCF(TTM)-1.98
OCFYN/A
SpS2.04
BVpS11.46
TBVpS11.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number19.67
Profitability
Industry RankSector Rank
ROA 10.12%
ROE 17.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 100.82%
GM N/A
FCFM N/A
ROA(3y)-12.16%
ROA(5y)-8.47%
ROE(3y)-49.6%
ROE(5y)-31.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 69.19%
Cap/Sales 46.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.09
Quick Ratio 2.09
Altman-Z 0.43
F-Score1
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)247.24%
Cap/Depr(5y)1644.95%
Cap/Sales(3y)163.79%
Cap/Sales(5y)566.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%173.81%
EPS Next Y-67.57%
EPS Next 2Y-77.4%
EPS Next 3Y-34.97%
EPS Next 5YN/A
Revenue 1Y (TTM)20.32%
Revenue growth 3Y60.35%
Revenue growth 5Y252.85%
Sales Q2Q%91.73%
Revenue Next Year49.78%
Revenue Next 2Y30.65%
Revenue Next 3Y23.77%
Revenue Next 5Y27.19%
EBIT growth 1Y-41.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year257.35%
EBIT Next 3Y25.08%
EBIT Next 5Y36.19%
FCF growth 1Y-261.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-181%
OCF growth 3YN/A
OCF growth 5YN/A

MARA HOLDINGS INC / M44.DE FAQ

Can you provide the ChartMill fundamental rating for MARA HOLDINGS INC?

ChartMill assigns a fundamental rating of 3 / 10 to M44.DE.


What is the valuation status for M44 stock?

ChartMill assigns a valuation rating of 2 / 10 to MARA HOLDINGS INC (M44.DE). This can be considered as Overvalued.


How profitable is MARA HOLDINGS INC (M44.DE) stock?

MARA HOLDINGS INC (M44.DE) has a profitability rating of 2 / 10.


Can you provide the financial health for M44 stock?

The financial health rating of MARA HOLDINGS INC (M44.DE) is 3 / 10.